(Total Views: 553)
Posted On: 02/14/2022 1:50:29 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Cassandra X #118094
I think the synergies with other treatments is overrated but otherwise it's spot on. We know with PD-1/PD-L1 checkpoint inhibitors they would add little to leronlimab's effect on PD-L1. They mention PARP inhibitors which stop DNA repair but leronlimab already does that. Chemotherapy can induce cancer reoccurrence that is resistant to that chemotherapy.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)